CDRP Steering Committee UPMC McKeesport

1
CDRP Steering CommitteeUPMC McKeesport

• January 20th, 2006

2
Clinical Trials

• RTOG 232
• A phase III study comparing combined external
  beam radiation and transperineal interstitial
  permanent brachytherapy with brachytherapy alone
  for selected patients with intermediate risk
  prostatic carcinoma
• Anticipated accrual 4 males 2 black/2 white
• Status

3
Clinical Trials

• RTOG 315
• A randomized, double blind, placebo-controlled
  phase III study to determine the efficacy of
  sandostatin lar? depot (ostreotide
  chemoradiation-induced diarrhea in patients with
  anal or rectal cancer
• Anticipated accrual 3 (1 white female 1 white
  male 1 black male)
• Status Open Mercy pending IRB at 4 other sites

4
Clinical Trials

• RTOG 126
• A phase III randomized study of high dose
  3D-CRT/IMRT versus standard dose 3D-CRT/IRMT in
  patients treated for localized prostate cancer
• Anticipated accrual 1 white male
• Status Open at McKeesport, Murtha, Jameson not
  open Mercy pending IRB Somerset

5
Clinical Trials

• RTOG 235/ACRIN 6668
• Positron emission tomography pre- and
  post-treatment assessment for locally advanced
  non-small cell lung carcinoma
• Anticipated accrual 7 (1 black female/2 black
  males 2 white female/2 white male)
• Status Pending PET machine accreditation
  McKeesport/Murtha pending IRB Somerset not open
  at Mercy pending IRB Jameson

6
Clinical Trials

• RTOG 214
• A Phase III comparison of prophylactic cranial
  irradiation versus observation in patients with
  locally advanced non-small cell lung cancer
• Accruals to date 2 white male
• Anticipated accrual 5 (2 black male 1 white
  female/2 white male)
• Status Open Mercy, Murtha, Jameson, McKeesport
  Somerset pending IRB

7
Publications

• ASTRO Poster (10/05)
• Analysis of best practice treatment patterns
  for a radiation oncology community outreach group
  (ROCOG) engaged in cancer disparities research
  (Proctor, et al)
• RSNA Poster (11/05)
• Use of formative evaluation to measure progress
  within start-up programs (Morgenlander, et al)

8
Publications

• American Telemedicine Assoc. Poster (5/06)
• A multi-institutional regional/mobility model
  Deployment for TELESYNERGY? (Schenken, et al)
• Academy Health submitted
• Evaluation of the tailored patient navigator
  programs for the underserved populations with
  cancer (Lin, et al)

9
Publications

• An evolving Plan for Evaluation of the Web-based
  Communication and TELESYNERGY Components of the
  UPMC McKeesport/ROCOG Minority Outreach Project
• by Edmund M. Ricci, Ph.D.(Professor and Director,
  Institute for Evaluation Science in Community
  Health, University of Pittsburgh), and Larry
  Schenken, Ph.D. in preparation
• A Community Hospital-based, Collaborative
  Research Program to Reduce Radiation Oncology
  Disparities A Developmental Case Study
• (Part 1 of a 3 part series)
• by Morgenlander, Heron, Schenken, Proctor,
  Govern, Kalnicki, Herberman, Baum, Melani,
  Feinstein (proposed authorline manuscript under
  internal review)

10
TELESYNERGY

• Assurance of CME credit provided by Barbara
  Barnes, M.D., Vice President for Contracts,
  Grants, IP and CME programs for the University of
  Pittsburgh Medical Centers for all TELESYNERGY
  based professional programs, either within ROCOG
  partners, or with our Mentors. To be directed by
  Dr. Heron and Coordinated by Dr. Schenken.
• Antonio Ambrad, M.D. appointed clinical
  coordinator and ombudsman for TELESYNERGY
  utilization by oncology staff at UPMC McKeesport
• Enhanced linkage with Radiation Oncology resident
  training (Journal Club) at St. Louis. Concept
  initiated by Barb Klewien, and involving T.
  Michael White M.D., (Director of Medical
  Education at McKeesport), Larry Schenken, Ph.D.,
  Stasia Miaskiewicz, M.D. (Internal Medicine
  residency training Coordinator-McKeesport)

11
TELESYNERGY (cont)

• Continue to promote special programs facilitating
  interactions among our oncology staff and with
  Mentors e.g.Respiratory Gating Issues in
  Radiation Oncology and Joint Case/Pathology
  Reviews comparing live time histopathology, jpeg
  stored images, and web-based ultra-high
  resolution auto-scanned imaging systems

12
Patient Navigator Program

• In operation since January 2005 in 2 of 5
  institutions
• As of November 30, 2005, 100 patients consented
  to the program
• 59 at Mercy Hospital-urban hospital
• 41 at Jameson Hospital-rural hospital
• Top 3 primary barriers that Navigators deal with
  are
• Transportation (21)
• Insurance issues (12)
• Prescription coverage (10)

13
Patient Navigator Program

• Implementing program in 2 more institutions by
  end of January 2006
• Somerset Oncology Center-rural
• UPMC McKeesport-urban
• Physician education currently being completed in
  both institutions
• Navigators in place and being trained
• Didactic education program
• Mentoring by other Navigators
• Navigator program implemented in 5th institution
  in early spring, delay due to merger/funding